NOS2 and Parkinson disease: In PD rats, icariin has been shown to downregulate the levels of Iba-1, inhibit the activation of microglia, and decrease the release of IL-1β, TNF-α, NO, and iNOS by inhibiting the expression of the NF-κB/NLRP3 pathway.